YU YONG (VP, Clinical Trial Operations) sold 0.2% of their position (653.00 shares) of GENELUX CORP on the open market
Open‑market sale worth $1.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/5/2026ACC: 0001493152-26-036077
Officer· VP, Clinical Trial Operations
Since Jan 2023
-653.00
Net shares
Net seller
$1.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
653.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−653.00
Price / share
$2.94
Trade value
$1.92K
% of position
0.2%
8/4/2026
269.02K→268.37K
Total
Net shares
−653.00
Net value
-$1.92K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/4/2026 | S · Sale | −653.00 | $2.94 | $1.92K | 0.2% | 269.02K | 268.37K |
| Total | −653.00 | -$1.92K | ||||||
Derivative Transactions0
No derivative transactions reported